Reply to T. Hasegawa et al and I. Gross et al

Affiliations

Comment

Brian Leyland-Jones et al. J Clin Oncol. 2016.

. 2016 Nov 1;34(31):3820-3821.

doi: 10.1200/JCO.2016.68.7681.

¹ Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Els Vercammen and Liang Xiu, Janssen Research & Development, Raritan, NJ.

No abstract available

Comment on

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.
Leyland-Jones B, Bondarenko I, Nemsadze G, Smirnov V, Litvin I, Kokhreidze I, Abshilava L, Janjalia M, Li R, Lakshmaiah KC, Samkharadze B, Tarasova O, Mohapatra RK, Sparyk Y, Polenkov S, Vladimirov V, Xiu L, Zhu E, Kimelblatt B, Deprince K, Safonov I, Bowers P, Vercammen E. Leyland-Jones B, et al. J Clin Oncol. 2016 Apr 10;34(11):1197-207. doi: 10.1200/JCO.2015.63.5649. Epub 2016 Feb 8. J Clin Oncol. 2016. PMID: 26858335 Clinical Trial.
Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia.
Gross I, Farmer S, Hofmann A, Ozawa S, Shander A, Aapro M. Gross I, et al. J Clin Oncol. 2016 Nov 1;34(31):3819-3820. doi: 10.1200/JCO.2016.67.7377. J Clin Oncol. 2016. PMID: 27507872 Free PMC article. No abstract available.
How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?
Hasegawa T, Uno H, Wei LJ. Hasegawa T, et al. J Clin Oncol. 2016 Nov 1;34(31):3818. doi: 10.1200/JCO.2016.67.2055. J Clin Oncol. 2016. PMID: 27507875 Free PMC article. No abstract available.

1. Gross I, Farmer S, Hofmann A, et al. Critical role of iron in epoetin alfa treatment for chemotherapy-associated anemia. J Clin Oncol. 2016;34:3819. - PMC - PubMed
1. Leyland-Jones B, Bondarenko I, Nemsadze G, et al. A randomized, open-label, multicenter, phase III study of epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy. J Clin Oncol. 2016;34:1197–1207. - PubMed
1. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant. 14:1-50, 1999 (suppl 5) - PubMed
1. Aapro MS, Link H. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist. 13:33-36, 2008 (suppl 3) - PubMed
1. Aapro M, Leonard RC, Barnadas A, et al. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study. J Clin Oncol. 2008;26:592–598. - PubMed